Arcosa (ACA)

Industrials · Engineering & Construction
$146.65 +0.11% on the day Market cap $6.9B 52-week range $89.03 to $147.05 Prices as of Oct 7, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Free cash flow growth the price needs
14% a year for 10 years

At a market value of $6.9B, Arcosa's free cash flow of $176M (fiscal 2025) would need to grow about 14% a year for the stock to be worth today's price. That is faster than the company has grown its free cash flow over the last 9 years.

Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from Arcosa's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.

Implied by the price13.9% a year
Free cash flow, last 9 years2.3% a year
Revenue, same period6.0% a year
Price to free cash flow39.5x

Fundamental grade

C

Five factors scored 1 to 9 from ACA's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation4
Profitability6
Growth4
Financial health7
Cash efficiency4

Key numbers

P/E (trailing)31.6x
P/E (forward)39.0x
Price / free cash flow39.5x
EV / EBITDA16.3x
Price / sales2.53x
Price / book2.74x
Revenue growth-10.6%
Operating margin11.8%
Net margin17.9%
Return on equity16.5%
Dividend yield0.13%
Debt / equity0.78x

Results from SEC filings

Fiscal years, from Arcosa's 10-K filings. The deep dive has 15+ years, quarters and every line.

Fiscal year20212022202320242025
Revenue$2.0B$2.2B$2.3B$2.6B$2.9B
Net income$70M$246M$159M$94M$208M
Free cash flow$81M$36M$58M$312M$176M
EPS (diluted)$1.42$5.05$3.26$1.91$4.24
Operating margin5.3%15.6%9.4%7.7%11.9%

Where the revenue comes from

Revenue by segments, fiscal 2025.

Construction Products$1.3B45%
Engineered Structures$1.2B41%
Transportation Products$383M13%

Superinvestors who own ACA

From each investor's latest 13F filing (what a 13F shows). 4 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Mario Gabelli
GAMCO Investors
Trimmed $25M0.23%Q2 2026
Jean-Marie Eveillard
First Eagle Investment Management
Added $19M0.03%Q2 2026
Eric Marshall
Hodges Capital Management
Added $11M0.72%Q2 2026
Cliff Asness
AQR Capital Management
Added $3M0.00%Q2 2026

Insider buying

Open-market purchases by Arcosa's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

No open-market insider purchases of ACA in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when ACA trades at or below it.

$

Free accounts get 3 price alerts. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

What growth does Arcosa's stock price imply?

At a market value of $6.9B, Arcosa would need its free cash flow to grow about 14% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 9 years its free cash flow grew 2% a year.

Are Arcosa insiders buying the stock?

No open-market insider purchases of ACA in the last 12 months, according to SEC Form 4 filings.

Which superinvestors own Arcosa?

4 of the superinvestors Investingly tracks hold ACA in their latest 13F, including Mario Gabelli, Jean-Marie Eveillard, Eric Marshall.

Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.